An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine ...
Mar 11, 2026
0
0
A Simon Fraser University study is pushing back against the "easy narrative" that not getting vaccinated is entirely a personal decision. Rather, vaccine hesitancy in Canada comes down to significant cultural, administrative, ...
Mar 11, 2026
0
0
New findings on how the human heart adapts to expressive music features, like loudness or tempo, could lay the foundations for targeted music-based "exercises" to support heart health. Led by King's College London, the study ...
Mar 11, 2026
0
0
More than a year after the second Trump administration began dismantling the US Agency for International Development (USAID), the global health consequences of this unprecedented loss in international aid continue to surface. ...
Mar 11, 2026
1
0
Understanding how aging reshapes the body and why physical function often declines over time has become a central focus of modern biomedical research. A new Yale School of Medicine (YSM) study, published in Aging Cell, points ...
Mar 11, 2026
0
0
In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...
Mar 11, 2026
0
0
Research conducted by University of Calgary scientists informed patient care when hundreds of children became sick from exposure to a severe strain of E. coli. Shiga toxin-producing Escherichia coli (STEC) is a bacterium ...
Mar 11, 2026
0
0
Tick-borne diseases are on the rise in the northeastern US, with many ticks carrying more than one pathogen, reports a recent analysis published in Ecosphere by researchers at Cary Institute of Ecosystem Studies and the SUNY ...
Mar 11, 2026
0
0
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, ...
Mar 11, 2026
0
0
In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the cancer. That would seem ...
Mar 11, 2026
0
0
